HealthFDA orders vision-loss warning on Ozempic, Zepbound and other GLP-1 drugs
The FDA ordered all GLP-1 drugs, such as Ozempic and Zepbound, to warn about a possible increased risk of NAION, a rare eye disease that can cause permanent vision loss.























